Sumitovant Biopharma aims to make a difference in people’s lives by rapidly developing innovative medicines, using a technology-enabled approach to drug discovery, development and commercialization.

The risks of using generative artificial intelligence to educate children and teens currently overshadow the benefits, according to a new study by the Brookings Institution's Center for Universal ...

In 2021, GSK invested £5.3 billion in research and development (R&D), further growing a budget that has built a pipeline of 43 medicines and 21 vaccines, almost half of which address infectious ...

A business.com editor verified this analysis to ensure it meets our standards for accuracy, expertise and integrity. Business.com earns commissions from some listed providers. Editorial Guidelines.